KBC Equity Fund Pharma C
| MVD-Fonds Rating | EDA |
|---|---|
  | - |
ISIN: BE0166584350 | WKN: 633868
KAG: KBC AM NV
NAV: 2.366,25 EUR am 22.10.2021
Portfolio
Watchlist
Kursalarm
Kennzahlen KBC Equity Fund Pharma C
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | +1,75% | +15,48% | +28,88% | +53,67% | +77,65% | +298,53% | +377,27% |
| Volatilität | +14,12% | +10,35% | +12,40% | +18,20% | +16,21% | +15,33% | +17,11% |
| Sharpe Ratio | +1,70 | +3,27 | +2,37 | +0,88 | +0,79 | +1,00 | +0,43 |
| Bester Monat | - | +6,64% | +6,64% | +11,33% | +11,33% | +11,33% | +11,33% |
| Schl. Monat | - | -2,72% | -4,84% | -10,35% | -10,35% | -10,35% | -12,15% |
| Max. Verlust | -4,24% | -5,36% | -6,19% | -28,06% | -28,06% | -28,06% | -60,14% |
Monatsperformance KBC Equity Fund Pharma C
| 2021 | 2020 | 2019 | 2018 | 2017 | |
| Januar | +4,17% | -0,50% | +9,54% | +2,43% | -0,22% |
| Februar | -2,42% | -5,95% | +2,97% | -3,63% | +7,71% |
| März | +5,48% | -4,31% | +2,65% | -2,87% | +0,32% |
| April | +2,03% | +11,33% | -1,85% | +3,25% | +0,24% |
| Mai | +1,13% | +2,14% | -1,57% | +5,59% | -2,60% |
| Juni | +6,64% | -1,47% | +4,11% | +1,50% | +1,10% |
| Juli | +4,04% | -1,69% | +1,48% | +6,18% | -3,72% |
| August | +3,23% | +0,96% | +0,70% | +3,78% | -0,45% |
| September | -2,72% | +0,46% | -0,38% | +0,80% | +1,37% |
| Oktober | +3,80% | -4,84% | +1,97% | -4,82% | -1,95% |
| November | - | +5,54% | +6,02% | +3,56% | -0,76% |
| Dezember | - | -0,41% | +1,46% | -10,35% | -0,35% |
| Gesamt | +27,95% | +0,06% | +30,04% | +4,14% | +0,26% |
Diese Fonds könnten Sie auch interessieren
Vergleichen Sie diese Fonds mit Ihrem ausgewähltem Fonds (KBC Equity Fund Pharma) oder suchen Sie weitere Top-Fonds zum Thema Aktien (Branche Gesundheit/Pharma) weltweit in EUR:
Fonds vergleichenWeitere ähnliche Fonds